Sequence variation occurs in CD4 epitopes during early HIV infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 46, Issue 3, 2007, Pages 261-267

  Rychert, Jenna ^a   Saindon, Suzanne ^a   Placek, Sarah ^a   Daskalakis, Demetre ^b   Rosenberg, Eric S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute HIV infection; CD4+ T cell response; Viral evolution

Indexed keywords

AMINO ACID; CD4 ANTIGEN; GAMMA INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIGENS, CD4; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; GENES, GAG; GENES, NEF; HISTOCOMPATIBILITY TESTING; HIV INFECTIONS; HUMANS; INTEGRASES; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; MUTATION; VARIATION (GENETICS);

EID: 37349035817     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181514427     Document Type: Article

References (25)

1. McMichael AJ, Rowland-Jones SL. Cellular immune responses to HIV. Nature. 2001;410:980-987.
2. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68:4650-4655.
3. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999;283:857-860.
4. Kaufmann DE, Bailey PM, Sidney J, et al. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol. 2004;78:4463-4477.
5. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 1997;278:1447-1450.
6. Boaz MJ, Waters A, Murad S, et al. Presence of HIV-1 Gag-specific IFNgamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. J Immunol. 2002;169:6376-6385.
7. Sloan-Lancaster J, Allen PM. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol. 1996;14:1-27.
8. Bouhdoud L, Villain P, Merzouki A, et al. T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide. J Virol. 2000;74:2121-2130.
9. Brown WC, Brayton KA, Styer CM, et al. The hypervariable region of Anaplasma marginale major surface protein 2 (MSP2) contains multiple immunodominant CD4+ T lymphocyte epitopes that elicit variant-specific proliferative and IFN-gamma responses in MSP2 vaccinates. J Immunol. 2003;170:3790-3798.
10. Burt DS, Mills KH, Skehel JJ, et al. Diversity of the class II (I-Ak/I-Ek)-restricted T cell repertoire for influenza hemagglutinin and antigenic drift. Six nonoverlapping epitopes on the HA1 subunit are defined by synthetic peptides. J Exp Med. 1989;170:383-397.
11. Fenoglio D, Li Pira G, Lozzi L, et al. Natural analogue peptides of an HIV-1 GP120 T-helper epitope antagonize response of GP120-specific human CD4 T-cell clones. J Acquir Immune Defic Syndr. 2000;23:1-7.
12. Frasca L, Del Porto P, Tuosto L, et al. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells. J Immunol. 1999;163:650-658.
13. Harcourt GC, Garrard S, Davenport MP, et al. HIV-1 variation diminishes CD4 T lymphocyte recognition. J Exp Med. 1998;188:1785-1793.
14. Hunziker L, Recher M, Ciurea A, et al. Antagonistic variant virus prevents wild-type virus-induced lethal immunopathology. J Exp Med. 2002;196:1039-1046.
15. Lekutis C, Letvin NL. Substitutions in a major histocompatibility complex class II-restricted human immunodeficiency virus type 1 gp120 epitope can affect CD4+ T-helper-cell function. J Virol. 1998;72:5840-5844.
16. Millar AE, Wleklinski-Lee M, Kahn SJ. The surface protein superfamily of Trypanosoma cruzi stimulates a polarized Th1 response that becomes anergic. J Immunol. 1999;162:6092-6099.
17. Plebanski M, Lee EA, Hill AV. Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein. Parasitology. 1997;115(Suppl):S55-S66.
18. Wang H, Eckels DD. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J Immunol. 1999;162:4177-4183.
19. Koeppe JR, Campbell TB, Rapaport EL, et al. HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia. J Acquir Immune Defic Syndr. 2006;41:140-148.
20. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens. 1995;46:355-367.
21. Korber BT, Brander C, Haynes BF, et al, eds. HIV Molecular Immunology 2005. Los Alamos, NM: Los Alamos National Laboratory Theoretical Biology and Biophysics; 2005. LA-UR 06-0036.
22. Wang H, Bian T, Merrill SJ, et al. Sequence variation in the gene encoding the nonstructural 3 protein of hepatitis C virus: evidence for immune selection. J Mol Evol. 2002;54:465-473.
23. Wang JH, Layden TJ, Eckels DD. Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response. Hum Immunol. 2003;64:662-673.
24. Abrams SI, Schlom J. Rational antigen modification as a strategy to upregulate or downregulate antigen recognition. Curr Opin Immunol. 2000;12:85-91.
25. Cosimi LA, Rosenberg ES. The characterization of HIV-1 specific CD4+ T helper epitopes IV-45. In: Korber BC, Haynes BF, Koup R, et al, eds. HIV Molecular Immunology 2000. Los Alamos, NM: Los Alamos National Laboratory Theoretical Biology and Biophysics; 2000.